Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Net Asset Quality Index
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Net Asset Quality Index of 90.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥8.59 Billion minus total liabilities of CN¥842.81 Million yields net assets of CN¥7.74 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shanghai Allist Pharmaceuticals Co. Ltd. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Allist Pharmaceuticals Co. Ltd. A Net Asset Quality Index Over Time (2017–2025)
This chart shows how Shanghai Allist Pharmaceuticals Co. Ltd. A's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 90.2%, representing net assets of CN¥7.74 Billion against total assets of CN¥8.59 Billion CNY. See working capital position of Shanghai Allist Pharmaceuticals Co. Ltd. to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Shanghai Allist Pharmaceuticals Co. Ltd. (688578) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 182.2% | CN¥14.40 Billion | CN¥7.90 Billion | CN¥-6.50 Billion | ▲ +92.9 pp |
| 2024 | 89.3% | CN¥5.28 Billion | CN¥5.92 Billion | CN¥633.32 Million | ▼ -1.7 pp |
| 2023 | 91.0% | CN¥3.98 Billion | CN¥4.38 Billion | CN¥394.22 Million | ▼ -1.6 pp |
| 2022 | 92.6% | CN¥3.19 Billion | CN¥3.44 Billion | CN¥255.12 Million | ▼ -2.4 pp |
| 2021 | 95.0% | CN¥2.97 Billion | CN¥3.13 Billion | CN¥156.99 Million | ▼ -1.4 pp |
| 2020 | 96.4% | CN¥2.88 Billion | CN¥2.99 Billion | CN¥109.01 Million | ▲ +7.2 pp |
| 2019 | 89.2% | CN¥1.18 Billion | CN¥1.33 Billion | CN¥144.02 Million | ▲ +70.2 pp |
| 2018 | 18.9% | CN¥71.04 Million | CN¥375.00 Million | CN¥303.96 Million | ▼ -56.0 pp |
| 2017 | 75.0% | CN¥381.26 Million | CN¥508.63 Million | CN¥127.37 Million | — |